Chronic Pain DEA Decriminalization Treatment 
Veriheal
FEBRUARY 23, 2024
As the Drug Enforcement Administration (DEA) and federal government draw closer to moving cannabis from a Schedule I to a Schedule III substance , more groups have begun to put their weight behind the movement. Countless veterans suffer from these ailments, and, as such, are pushing for access to as many treatments and therapies as possible.
Veriheal
NOVEMBER 11, 2023
According to the United States Drug Enforcement Administration (DEA), Schedule One drugs are “drugs with no currently accepted medical use and a high potential for abuse.” Common challenges that veterans face include chronic pain, PTSD, depression, insomnia, traumatic brain injury, broken bones, and musculoskeletal ailments.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Canna Law Blog
MARCH 4, 2020
People are increasingly using ketamine for ailments that resist treatment through traditional pharmaceutical drugs. Recently, the decriminalization of psilocybin (by various cities) has been in the news as an emerging medicine. major depressive disorder, post-traumatic stress disorder, acute suicidality).
Cannabis Law Report
JULY 9, 2021
Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. Published Via JD Supra. The state of the law on psychedelic substances is in flux. 10; 312.80-88;
Canna Law Blog
MARCH 4, 2020
People are increasingly using ketamine for ailments that resist treatment through traditional pharmaceutical drugs. Recently, the decriminalization of psilocybin (by various cities) has been in the news as an emerging medicine. major depressive disorder, post-traumatic stress disorder, acute suicidality).
Cannabis Law Report
SEPTEMBER 23, 2019
The AAFP urges its members to be involved in the diagnosis, treatment, and prevention of substance use, as well as secondary diseases impacted or caused by use. However, the AAFP supports decriminalization of possession of marijuana for personal use. The World Health Organization (WHO) reports approximately 2.5% In the Exam Room.
Expert insights. Personalized for you.
99 
Let's personalize your content